Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%.
Senate Majority Leader Nicole Cannizzaro and Assembly Speaker Steve Yeager made the comments during a meeting of the Interim Finance Committee after Senate Minority Leader Robin Titus suggested there ...
Potenziare l’Arpa Sicilia attraverso nuove risorse umane ed economiche, con un finanziamento di due milioni di euro, nelle aree maggiormente critiche. “Per i prossimi tre anni l’Agenzia ...
Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...
The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.
Making the world smarter, happier, and richer.
Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback